secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001213900-25-054315
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 4.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed special meeting lacks quorum for share issuance vote; appoints new auditor CBIZ
--------------------------------------------------------------------------------

- Special meeting on June 13, 2025 lacked quorum; ~60% of voted shares favored share issuance proposal but no vote held. Board evaluating next steps.
- Marcum resigned as auditor after acquisition by CBIZ; Board appointed CBIZ as independent auditor for FY2025. No disagreements; prior material weakness remediated.
- Company amended SEPA with Yorkville to allow suspension of registration statement during black-out periods, subject to restrictions similar to insider trading policies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025054315/0001213900-25-054315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025054315/ea0245506-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-054315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer